ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
gumboot
|
630 |
265K |
7 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
630
|
265K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
gumboot
|
663 |
245K |
7 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
663
|
245K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
gumboot
|
630 |
265K |
4 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
630
|
265K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
gumboot
|
24 |
7.3K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
24
|
7.3K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
gumboot
|
29 |
10K |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
29
|
10K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Completion of Placement and Institutional Entitlement Offer
|
|
gumboot
|
4 |
2.2K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
4
|
2.2K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Becoming a substantial holder
|
|
gumboot
|
1 |
868 |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
1
|
868
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Proposed issue of securities - ATH
|
|
gumboot
|
4 |
1.5K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Proposed issue of securities - ATH
|
|
gumboot
|
4 |
1.5K |
2 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
1.5K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
gumboot
|
26 |
9.2K |
0 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
26
|
9.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
gumboot
|
32 |
11K |
4 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
32
|
11K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
News: ATH Alterity Therapeutics Seeks Trading Halt
|
|
gumboot
|
18 |
6.1K |
0 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
18
|
6.1K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial
|
|
gumboot
|
55 |
15K |
4 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
55
|
15K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial
|
|
gumboot
|
55 |
15K |
5 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
55
|
15K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
A new PBT2 paper
|
|
gumboot
|
7 |
2.5K |
6 |
28/01/23 |
28/01/23 |
ASX - By Stock
|
7
|
2.5K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: IND approval from the FDA for theranostic SAR-Bombesin trial
|
|
gumboot
|
4 |
2.3K |
7 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
4
|
2.3K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: US FDA Approval for IND Application for ATH434 for MSA
|
|
gumboot
|
13 |
7.4K |
5 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
13
|
7.4K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
New PBT2 paper by the inventors
|
|
gumboot
|
9 |
2.9K |
0 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9
|
2.9K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 4C and Quarterly Cash Flow Report
|
|
gumboot
|
13 |
5.0K |
6 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
13
|
5.0K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 4C and Quarterly Cash Flow Report
|
|
gumboot
|
13 |
5.0K |
4 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
13
|
5.0K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Shorts 173K
|
|
gumboot
|
1 |
524 |
0 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
1
|
524
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
gumboot
|
10 |
4.0K |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
10
|
4.0K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
PBT2 News
|
|
gumboot
|
24 |
7.8K |
2 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
24
|
7.8K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: ATH Annual General Meeting Presentation
|
|
gumboot
|
31 |
9.4K |
1 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
31
|
9.4K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: ATH Annual General Meeting Presentation
|
|
gumboot
|
31 |
9.4K |
5 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
31
|
9.4K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Data Advance ATH434 as Neurodegeneration treatment
|
|
gumboot
|
26 |
7.5K |
6 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
26
|
7.5K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Antibiotic-resistant problem: Urgent, serious and concerns of CDC (USA)
|
|
gumboot
|
12 |
3.5K |
4 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
12
|
3.5K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Expanded ATH434 Phase 2 Clinical Development Program
|
|
gumboot
|
29 |
9.2K |
6 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
29
|
9.2K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Iron, central in the PD pathology,
|
|
gumboot
|
3 |
1.2K |
3 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
3
|
1.2K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Experimental method to study macula degeneration
|
|
gumboot
|
4 |
1.7K |
7 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
4
|
1.7K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Iron chelators as antibiotics, a new possibility for Alterity?
|
|
gumboot
|
2 |
892 |
1 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
2
|
892
|
1
|
|
ASX - By Stock
|
ORG |
Re:
ORG- What fugazi is going on
|
|
gumboot
|
187 |
71K |
3 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
187
|
71K
|
3
|
|
ASX - By Stock
|
ORG |
Re:
ORG- What fugazi is going on
|
|
gumboot
|
187 |
71K |
2 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
187
|
71K
|
2
|
|
ASX - By Stock
|
EEG Oil & Gas |
Re:
HUGE NEWS - Falcon/Origin - Amungee
|
|
gumboot
|
16 |
8.6K |
0 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
16
|
8.6K
|
0
|
|
ASX - By Stock
|
EEG Oil & Gas |
Re:
HUGE NEWS - Falcon/Origin - Amungee
|
|
gumboot
|
16 |
8.6K |
0 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
16
|
8.6K
|
0
|
|
ASX - By Stock
|
EEG Oil & Gas |
Re:
HUGE NEWS - Falcon/Origin - Amungee
|
|
gumboot
|
16 |
8.6K |
0 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
16
|
8.6K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Today's Endpoints News Lead Article Regarding Eli Lilly Actions and Plans
|
|
gumboot
|
27 |
9.5K |
3 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
27
|
9.5K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
NEW PAPER about ATH434 and endothelial cells !!!!
|
|
gumboot
|
19 |
6.6K |
7 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
19
|
6.6K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
NEW PAPER about ATH434 and endothelial cells !!!!
|
|
gumboot
|
19 |
6.6K |
5 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
19
|
6.6K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Publication Demonstrates ATH434 is Neuroprotective
|
|
gumboot
|
16 |
7.0K |
2 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
16
|
7.0K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Publication Demonstrates ATH434 is Neuroprotective
|
|
gumboot
|
16 |
7.0K |
5 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
16
|
7.0K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Publication Demonstrates ATH434 is Neuroprotective
|
|
gumboot
|
16 |
7.0K |
6 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
16
|
7.0K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
gumboot
|
25 |
10K |
2 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
25
|
10K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Up 212% pre market
|
|
gumboot
|
120 |
52K |
5 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
120
|
52K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Antibiotic resistance fund aims 2-4 new antibiotics by 2030
|
|
gumboot
|
10 |
3.3K |
0 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
10
|
3.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to present at MST Access Investor Conference
|
|
gumboot
|
10 |
4.0K |
1 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
10
|
4.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Any news ??, up in NY 8%
|
|
gumboot
|
26 |
10K |
5 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
26
|
10K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 3G
|
|
gumboot
|
9 |
3.1K |
0 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
9
|
3.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 3G
|
|
gumboot
|
9 |
3.1K |
2 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
9
|
3.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to present at Global Life Science Conference
|
|
gumboot
|
5 |
2.6K |
1 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
5
|
2.6K
|
1
|
|